Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://actgnetwork.org/2022/08/15/actg-announces-launch-of-activ-2d-a-global-phase-3-trial-of-the-novel-investigational-covid-19-oral-antiviral-agent-s%e2%80%91217622/
Research Institution
ACTG
Short Title
ACTG Announces Launch Of ACTIV-2d, A Global Phase 3 Trial of The Novel Investigational COVID-19 Oral Antiviral Agent S‑217622